DST awards Rs 60 crore to Mumbai Biocluster for innovation in biopharmaceuticals
Divyansh | March 5, 2024 | 03:21 PM IST | 1 min read
ICT Mumbai, IIT Bombay, TIFR, ACTREC and Khalsa College have formed Mumbai Biocluster to boost India's biopharmaceutical ecosystem.
NEW DELHI: The department of science and technology's (DST) SATHI initiative has granted Rs 60 crore to the Mumbai Biocluster, which comprises institutions such as Institute of Chemical Technology (ICT) Mumbai, IIT Bombay, Tata Institute of Fundamental Research (TIFR), Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) and Khalsa College.
Led by ICT Mumbai's vice-chancellor AB Pandit and DST-SATHI principal investigator Ratnesh Jain, the Mumbai Biocluster aims at catalysing innovation in biopharmaceuticals. Supported by Prasanna Venkatraman from ACTREC, Pratiksha Palahe from Khalsa College, Sudipta Maiti from TIFR, and Rohit Srivastava from IIT Bombay, the collaborative effort will accelerate the development of critical therapies for diseases like cancer, rare diseases, and infectious diseases.
Mumbai biocluster’s objective
The biocluster will serve as an accelerator for startups, academia, MSMEs, and industries, providing state-of-the-art infrastructure and expertise for faster development of biopharmaceutical products. With a focus on monoclonal antibodies, vaccines, mRNA technology, and cell and gene therapy, the facility will address key challenges faced during technology scale-up and validation in the drug development phase.
Also read BITS Pilani gets Rs 60 crore from DST to set up advanced research facility under SATHI scheme
Central to the biocluster's mission is the provision of a good manufacturing practice (GMP) facility, enabling drug development at an affordable cost. By bridging the gap between research and commercialization, the Mumbai Biocluster aims to propel India to the forefront of biopharmaceutical innovation, driving economic growth and improving healthcare outcomes. With the support of the DST-SATHI grant and the collective expertise of its member institutions, the Mumbai Biocluster is poised to revolutionise the landscape of biopharmaceutical research and development in India, the ICT said.
Follow us for the latest education news on colleges and universities, admission, courses, exams, research, education policies, study abroad and more..
To get in touch, write to us at news@careers360.com.
Next Story
]Featured News
]- Maharashtra eases university teacher recruitment norms; academic weightage cut to 60% from 75%
- UP Budget 2026-27: Vocational education funds up 88%; 14 new medical colleges; school outlay highest
- 3 yrs after UGC guidelines, 80% central universities yet to appoint professors of practice, private ones lead
- NMC approves record 20,098 new MBBS, PG medical seats, 777 after initial rejection
- 2 years into paramedical courses, students find themselves in vocational training; 300 protest in North Bengal
- Vidya Pravesh: 4.2 crore students across 8.9 lakh schools covered, but numbers now falling consistently
- Over 7 lakh Kendriya Vidyalaya students assessed via education ministry’s TARA app, 1.46 lakh on career tool
- Caste on Campus: The shape of discrimination in universities and why many back UGC equity regulations
- Across Telangana’s new government medical colleges, 26 depts empty, 31 with single teachers: Doctors’ survey
- ‘No TET’: School teachers’ jobs at risk, hundreds in Delhi to rally against mandatory eligibility tests